LOGIN  |  REGISTER
Viking Therapeutics

Recent Insider Transactions

Company
Name / Role
Date
Type
Price
# Shares
Value
Balance
NASDAQ SXTP 60 Degrees Pharmaceuticals
XU CHERYL / director
12/16/2024
Buy
$1.45
2,000
$3K
54,078
NASDAQ SXTP 60 Degrees Pharmaceuticals
XU CHERYL / director
12/12/2024
Buy
$1.80
2,500
$5K
46,078
NASDAQ SXTP 60 Degrees Pharmaceuticals
XU CHERYL / director
12/13/2024
Buy
$1.60
1,500
$2K
47,578
NASDAQ SXTP 60 Degrees Pharmaceuticals
XU CHERYL / director
12/13/2024
Buy
$1.58
1,500
$2K
49,078
NASDAQ SXTP 60 Degrees Pharmaceuticals
XU CHERYL / director
12/13/2024
Buy
$1.55
1,500
$2K
50,578
NASDAQ SXTP 60 Degrees Pharmaceuticals
XU CHERYL / director
12/13/2024
Buy
$1.52
1,500
$2K
52,078
NASDAQ SXTP 60 Degrees Pharmaceuticals
XU CHERYL / director
12/12/2024
Buy
$1.85
2,500
$5K
43,578
NYSE ABBV AbbVie
Buckbee Kevin K / officer: SVP, CONTROLLER
12/16/2024
Sell
$172.24
1,800
$310K
6,983
NASDAQ ACCD Accolade
Cavanaugh Robert N / officer: President
12/17/2024
Sell
$3.43
156
$535
213,295
NASDAQ ACCD Accolade
Barnes Stephen H. / officer: Chief Financial Officer
12/17/2024
Sell
$3.43
123
$422
220,463
NYSE ADCT ADC Therapeutics
Redmile Group, LLC / 10 percent owner
12/11/2024
Buy
$2.28
50,000
$114K
13.10M
NYSE ADCT ADC Therapeutics
Redmile Group, LLC / 10 percent owner
12/11/2024
Buy
$3.81
50,000
$191K
13.15M
NYSE ADCT ADC Therapeutics
Redmile Group, LLC / 10 percent owner
12/11/2024
Buy
$2.28
50,000
$114K
15.62M
NYSE ADCT ADC Therapeutics
Redmile Group, LLC / 10 percent owner
12/11/2024
Buy
$3.81
50,000
$191K
15.67M
NYSEAMEX AIM AIM ImmunoTech
Equels Thomas K / director, officer: CEO & President
12/18/2024
Buy
$0.21
22,727
$5K
1.68M
NYSEAMEX AIM AIM ImmunoTech
MITCHELL WILLIAM M / director
12/19/2024
Sell
$0.19
4,580
$884
118,549
NASDAQ AKRO Akero Therapeutics
Rolph Timothy / officer: Chief Scientific Officer
12/17/2024
Sell
$31.10
3,800
$118K
178,337
NASDAQ AKRO Akero Therapeutics
Yale Catriona / officer: Chief Development Officer
12/16/2024
Sell
$29.11
9,074
$264K
95,648
NASDAQ AKRO Akero Therapeutics
Lamy Patrick / officer: Senior VP, Commercial Strategy
12/16/2024
Sell
$29.13
1,000
$29K
34,258
NASDAQ ALHC Alignment Health
Maroney Dawn Christine / officer: President, Markets
12/16/2024
Sell
$11.33
30,000
$340K
1.64M
NASDAQ AMPH Amphastar Pharmaceuticals
Zhou Rong / officer: SENIOR EVP, PRODUCTION CENTER
12/13/2024
Sell
$45.23
8,000
$362K
118,469
NASDAQ AMPH Amphastar Pharmaceuticals
Zhou Rong / officer: SENIOR EVP, PRODUCTION CENTER
12/12/2024
Sell
$44.43
7,000
$311K
118,469
NASDAQ ANIP ANI Pharmaceuticals
CAREY STEPHEN P. / officer: SVP & CFO
12/17/2024
Sell
$55.79
7,500
$418K
154,468
NASDAQ ANIP ANI Pharmaceuticals
Cook Meredith / officer: SR. VP, GENERAL COUNSEL & SEC.
12/13/2024
Sell
$56.24
250
$14K
55,988
NASDAQ APGE Apogee Therapeutics
McKenna Mark C. / director
12/12/2024
Buy
$49.02
7,500
$368K
7,500
NASDAQ APGE Apogee Therapeutics
McKenna Mark C. / director
12/12/2024
Buy
$49.85
12,500
$623K
20,000
NASDAQ APGE Apogee Therapeutics
Dambkowski Carl / officer: Chief Medical Officer
12/11/2024
Sell
$50.00
455
$23K
258,073
NASDAQ APGE Apogee Therapeutics
Dambkowski Carl / officer: Chief Medical Officer
12/11/2024
Sell
$48.62
4,085
$199K
258,528
NASDAQ ARQT Arcutis Biotherapeutics
Watanabe Todd Franklin / director, officer: See Remarks
12/20/2024
Sell
$15.17
15,000
$228K
823,430
NASDAQ ARDX Ardelyx
MOTT DAVID M / director
12/19/2024
Buy
$4.67
213,300
$997K
1.64M
NASDAQ ARWR Arrowhead Pharmaceuticals
Anzalone Christopher Richard / director, officer: Chief Executive Officer
12/18/2024
Sell
$20.52
12,653
$260K
3.70M
NASDAQ ARWR Arrowhead Pharmaceuticals
Anzalone Christopher Richard / director, officer: Chief Executive Officer
12/23/2024
Sell
$19.59
12,563
$246K
3.78M
NASDAQ ARWR Arrowhead Pharmaceuticals
GIVEN DOUGLAS B / director
12/17/2024
Sell
$22.04
547
$12K
124,167
NASDAQ ARWR Arrowhead Pharmaceuticals
GIVEN DOUGLAS B / director
12/16/2024
Sell
$21.90
5,000
$110K
124,714
NASDAQ ARWR Arrowhead Pharmaceuticals
Waddill William D. / director
12/17/2024
Sell
$22.04
3,747
$83K
40,378
NASDAQ ARWR Arrowhead Pharmaceuticals
Vakiener Victoria / director
12/16/2024
Sell
$21.91
8,994
$197K
21,211
NASDAQ ARWR Arrowhead Pharmaceuticals
Waddill William D. / director
12/16/2024
Sell
$21.90
3,748
$82K
44,125
NASDAQ ARWR Arrowhead Pharmaceuticals
Anzalone Christopher Richard / director, officer: Chief Executive Officer
12/18/2024
Sell
$22.12
5,799
$128K
3.69M
NASDAQ ARWR Arrowhead Pharmaceuticals
Anzalone Christopher Richard / director, officer: Chief Executive Officer
12/18/2024
Sell
$21.74
8,260
$180K
3.69M
NASDAQ SPRY ARS Pharmaceuticals
Dorsey Brian / officer: Chief Operating Officer
12/11/2024
Sell
$12.43
15,000
$186K
6,024
NASDAQ SPRY ARS Pharmaceuticals
Lowenthal Richard E / director, 10 percent owner, officer: PRESIDENT AND CEO
12/17/2024
Sell
$11.67
50,000
$584K
1.10M
NASDAQ SPRY ARS Pharmaceuticals
Dorsey Brian / officer: Chief Operating Officer
12/12/2024
Sell
$12.30
25,000
$307K
6,024
NASDAQ SPRY ARS Pharmaceuticals
Chakma Justin / officer: Chief Business Officer
12/12/2024
Sell
$12.27
117,333
$1.439M
136,380
NASDAQ SPRY ARS Pharmaceuticals
Lowenthal Richard E / director, 10 percent owner, officer: PRESIDENT AND CEO
12/17/2024
Sell
$11.67
50,000
$584K
1.30M
NASDAQ SPRY ARS Pharmaceuticals
Chakma Justin / officer: Chief Business Officer
12/13/2024
Sell
$12.06
27,272
$329K
136,380
NASDAQ SPRY ARS Pharmaceuticals
Tanimoto Sarina / 10 percent owner, officer: CHIEF MEDICAL OFFICER
12/17/2024
Sell
$11.67
50,000
$584K
1.10M
NASDAQ SPRY ARS Pharmaceuticals
Tanimoto Sarina / 10 percent owner, officer: CHIEF MEDICAL OFFICER
12/17/2024
Sell
$11.67
50,000
$584K
1.30M
NASDAQ ASMB Assembly Biosciences
GILEAD SCIENCES, INC. / 10 percent owner
12/19/2024
Buy
$21.37
940,499
$20.098M
2.21M
NASDAQ AVDL Avadel Pharmaceuticals
MCHUGH THOMAS S / officer: Chief Financial Officer
12/13/2024
Buy
$10.44
2,300
$24K
87,800
NASDAQ RNA Avidity Biosciences
Boyce Sarah / director, officer: President and CEO
12/18/2024
Sell
$32.66
31,855
$1.040M
265,308
NASDAQ RNA Avidity Biosciences
MacLean Michael F / officer: Chief Financial Officer
12/18/2024
Sell
$32.66
11,151
$364K
82,942
NASDAQ RNA Avidity Biosciences
McCarthy Teresa / officer: Chief Human Resources Officer
12/16/2024
Sell
$33.26
25,000
$832K
94,018
NASDAQ RNA Avidity Biosciences
Flanagan W. Michael / officer: CSTO
12/18/2024
Sell
$32.66
12,742
$416K
72,647
NASDAQ RNA Avidity Biosciences
McCarthy Teresa / officer: Chief Human Resources Officer
12/18/2024
Sell
$32.66
11,151
$364K
82,867
NYSE BDX Becton Dickinson
Garrison Michael David / officer: EVP & President, Medical
12/19/2024
Sell
$223.33
2,838
$634K
6,141
CSE BETR BetterLife Pharma
Bjorgolfsson Thor / 10 percent owner
12/12/2024
Sell
$12.25
43
$527
869,435
CSE BETR BetterLife Pharma
Bjorgolfsson Thor / 10 percent owner
12/13/2024
Sell
$11.30
50,416
$569K
818,780
CSE BETR BetterLife Pharma
Bjorgolfsson Thor / 10 percent owner
12/13/2024
Sell
$12.04
239
$3K
869,196
NASDAQ BCYC Bicycle Therapeutics
BAKER BROS. ADVISORS LP / director, 10 percent owner:
12/16/2024
Buy
$15.34
457,631
$7.021M
10.00M
NASDAQ BCYC Bicycle Therapeutics
BAKER BROS. ADVISORS LP / director, 10 percent owner:
12/16/2024
Buy
$15.34
42,369
$650K
914,083
NASDAQ BCYC Bicycle Therapeutics
BAKER BROS. ADVISORS LP / director, 10 percent owner:
12/13/2024
Buy
$13.50
30,241
$408K
8.67M
NASDAQ BCYC Bicycle Therapeutics
BAKER BROS. ADVISORS LP / director, 10 percent owner:
12/13/2024
Buy
$13.50
2,809
$38K
790,763
NASDAQ BCYC Bicycle Therapeutics
BAKER BROS. ADVISORS LP / director, 10 percent owner:
12/13/2024
Buy
$13.63
59,995
$818K
8.73M
NASDAQ BCYC Bicycle Therapeutics
BAKER BROS. ADVISORS LP / director, 10 percent owner:
12/13/2024
Buy
$13.63
5,573
$76K
796,336
NASDAQ BCYC Bicycle Therapeutics
BAKER BROS. ADVISORS LP / director, 10 percent owner:
12/13/2024
Buy
$13.72
244,587
$3.357M
8.97M
NASDAQ BCYC Bicycle Therapeutics
BAKER BROS. ADVISORS LP / director, 10 percent owner:
12/13/2024
Buy
$13.72
22,722
$312K
819,058
NASDAQ BCYC Bicycle Therapeutics
BAKER BROS. ADVISORS LP / director, 10 percent owner:
12/13/2024
Buy
$13.80
566,814
$7.824M
9.54M
NASDAQ BCYC Bicycle Therapeutics
BAKER BROS. ADVISORS LP / director, 10 percent owner:
12/13/2024
Buy
$13.80
52,656
$727K
871,714
NASDAQ BLFS BioLife Solutions
Mathew Aby J. / officer: EVP & Chief Scientific Officer
12/17/2024
Sell
$27.16
13,196
$358K
263,119
NASDAQ BLFS BioLife Solutions
Mathew Aby J. / officer: EVP & Chief Scientific Officer
12/16/2024
Sell
$27.33
7,604
$208K
276,315
NASDAQ BTAI BioXcel Therapeutics
Yocca Frank / officer: Chief Scientific Officer
12/16/2024
Sell
$0.35
225
$79
28,931
NASDAQ BTAI BioXcel Therapeutics
Steinhart Richard I / officer: Chief Financial Officer
12/16/2024
Sell
$0.36
372
$133
20,932
NASDAQ BTAI BioXcel Therapeutics
Yocca Frank / officer: Chief Scientific Officer
12/16/2024
Sell
$0.36
205
$73
29,156
NASDAQ BTAI BioXcel Therapeutics
Steinhart Richard I / officer: Chief Financial Officer
12/16/2024
Sell
$0.36
205
$74
21,157
NASDAQ BTAI BioXcel Therapeutics
Mehta Vimal / director, 10 percent owner, officer: CEO and President
12/16/2024
Sell
$0.36
2,134
$773
59,605
NASDAQ BTAI BioXcel Therapeutics
Mehta Vimal / director, 10 percent owner, officer: CEO and President
12/16/2024
Sell
$0.36
983
$358
60,920
NASDAQ BTAI BioXcel Therapeutics
O'Neill Vincent / officer: See Remarks
12/16/2024
Sell
$0.35
165
$58
19,957
NASDAQ BPMC Blueprint Medicines
Hurley Ariel / officer: PRINCIPAL ACCOUNTING OFFICER
12/12/2024
Sell
$93.99
619
$58K
14,967
NASDAQ BPMC Blueprint Medicines
Hurley Ariel / officer: PRINCIPAL ACCOUNTING OFFICER
12/12/2024
Sell
$92.88
1,200
$111K
15,586
NYSEAMEX CLDI Calidi Biotherapeutics
Camaisa Allan / director, officer: CEO and Chairman of the Board
12/17/2024
Sell
$1.62
10,000
$16K
66,712
NASDAQ CRDF Cardiff Oncology
TANNENBAUM RENEE P / director
12/12/2024
Buy
$3.42
10,000
$34K
20,000
NASDAQ CRDF Cardiff Oncology
Levine James E. / officer: Chief Financial Officer
12/16/2024
Buy
$3.83
2,564
$10K
62,564
NASDAQ CRDF Cardiff Oncology
Levine James E. / officer: Chief Financial Officer
12/17/2024
Buy
$5.42
2,752
$15K
65,316
NASDAQ CRDF Cardiff Oncology
Levine James E. / officer: Chief Financial Officer
12/18/2024
Buy
$5.00
2,400
$12K
67,716
NASDAQ CCLD CareCloud
MUNTER CAMERON / director
12/11/2024
Sell
$4.10
30,000
$123K
159,000
NASDAQ RNAC Cartesian Therapeutics
SPRINGER TIMOTHY A / director, 10 percent owner:
12/19/2024
Buy
$18.93
3,376
$64K
8.48M
NASDAQ RNAC Cartesian Therapeutics
SPRINGER TIMOTHY A / director, 10 percent owner:
12/20/2024
Buy
$18.94
21,800
$413K
8.50M
NASDAQ RNAC Cartesian Therapeutics
SPRINGER TIMOTHY A / director, 10 percent owner:
12/23/2024
Buy
$19.00
5,181
$98K
8.51M
NASDAQ RNAC Cartesian Therapeutics
SPRINGER TIMOTHY A / director, 10 percent owner:
12/19/2024
Buy
$17.39
11,303
$197K
8.47M
NASDAQ RNAC Cartesian Therapeutics
SPRINGER TIMOTHY A / director, 10 percent owner:
12/19/2024
Buy
$18.35
10,529
$193K
8.48M
NASDAQ CSTL Castle Biosciences
MAETZOLD DEREK J / director, officer: Pres. & Chief Exec. Officer
12/13/2024
Sell
$28.47
113
$3K
5,747
NASDAQ CSTL Castle Biosciences
MAETZOLD DEREK J / director, officer: Pres. & Chief Exec. Officer
12/13/2024
Sell
$29.16
3,321
$97K
105,185
NASDAQ CSTL Castle Biosciences
MAETZOLD DEREK J / director, officer: Pres. & Chief Exec. Officer
12/17/2024
Sell
$28.76
112
$3K
84,762
NASDAQ CSTL Castle Biosciences
MAETZOLD DEREK J / director, officer: Pres. & Chief Exec. Officer
12/13/2024
Sell
$29.16
117
$3K
62,469
NASDAQ CSTL Castle Biosciences
MAETZOLD DEREK J / director, officer: Pres. & Chief Exec. Officer
12/13/2024
Sell
$28.47
10,164
$289K
108,506
NASDAQ CSTL Castle Biosciences
MAETZOLD DEREK J / director, officer: Pres. & Chief Exec. Officer
12/17/2024
Sell
$28.33
9,252
$262K
84,874
NASDAQ CSTL Castle Biosciences
MAETZOLD DEREK J / director, officer: Pres. & Chief Exec. Officer
12/13/2024
Sell
$28.47
357
$10K
62,586
NASDAQ CSTL Castle Biosciences
MAETZOLD DEREK J / director, officer: Pres. & Chief Exec. Officer
12/13/2024
Sell
$29.16
37
$1K
5,702
NASDAQ CSTL Castle Biosciences
MAETZOLD DEREK J / director, officer: Pres. & Chief Exec. Officer
12/13/2024
Sell
$29.16
124
$4K
73,101
NASDAQ CSTL Castle Biosciences
MAETZOLD DEREK J / director, officer: Pres. & Chief Exec. Officer
12/13/2024
Sell
$29.16
37
$1K
5,710
NASDAQ CSTL Castle Biosciences
MAETZOLD DEREK J / director, officer: Pres. & Chief Exec. Officer
12/13/2024
Sell
$28.47
381
$11K
73,225
NASDAQ CSTL Castle Biosciences
MAETZOLD DEREK J / director, officer: Pres. & Chief Exec. Officer
12/13/2024
Sell
$28.47
113
$3K
5,739
NASDAQ CSTL Castle Biosciences
MAETZOLD DEREK J / director, officer: Pres. & Chief Exec. Officer
12/16/2024
Sell
$28.83
11,059
$319K
94,126
NYSE CNC Centene
Samuels Theodore R. II / director
12/13/2024
Buy
$58.86
5,000
$294K
23,000
NYSE CNC Centene
COUGHLIN CHRISTOPHER J / director
12/16/2024
Buy
$59.44
10,000
$594K
36,357
NYSE CNC Centene
Greco Thomas / director
12/18/2024
Buy
$59.75
17,000
$1.016M
19,309
NYSE CNC Centene
BLUME JESSICA L. / director
12/16/2024
Buy
$59.48
250
$15K
250
NYSE CNC Centene
Dallas H James / director
12/16/2024
Buy
$59.01
1,693
$100K
1,693
NASDAQ CNTA Centessa Pharmaceuticals
Bush Tia L / officer: Chief Technology & Quality Ofc
12/17/2024
Sell
$18.00
17,813
$321K
147,615
NASDAQ CNTA Centessa Pharmaceuticals
Bush Tia L / officer: Chief Technology & Quality Ofc
12/16/2024
Sell
$16.36
9,611
$157K
147,615
NASDAQ CNTA Centessa Pharmaceuticals
SAHA SAURABH / director, officer: Chief Executive Officer
12/20/2024
Sell
$17.44
55,000
$959K
520,661
NASDAQ CNTA Centessa Pharmaceuticals
Anderson Karen M. / officer: Chief People Officer
12/17/2024
Sell
$17.32
10,624
$184K
71,525
NASDAQ CNTA Centessa Pharmaceuticals
Anderson Karen M. / officer: Chief People Officer
12/13/2024
Sell
$17.01
5,876
$100K
71,525
NASDAQ CNTA Centessa Pharmaceuticals
HUSSAIN IQBAL J / officer: General Counsel
12/16/2024
Sell
$16.39
77,705
$1.274M
125,785
NASDAQ CERS Cerus
Jensen Chrystal / officer: Chief Legal Officer
12/16/2024
Sell
$1.71
16,667
$29K
457,578
NASDAQ CERS Cerus
BJERKHOLT ERIC / director
12/12/2024
Sell
$1.79
20,000
$36K
162,133
NASDAQ CGON CG Oncology
POST LEONARD E / director
12/16/2024
Sell
$28.84
1,000
$29K
0
NASDAQ CGON CG Oncology
Song Hong Fang / director
12/16/2024
Sell
$28.00
700,000
$19.600M
3.00M
NASDAQ CKPT Checkpoint Therapeutics
GRAY WILLIAM GARRETT / officer: Chief Financial Officer
12/18/2024
Sell
$4.01
268,432
$1.076M
1.03M
NASDAQ CKPT Checkpoint Therapeutics
Oliviero James F III / director, officer: CEO, President and Director
12/19/2024
Sell
$3.38
220,230
$744K
3.19M
NASDAQ CKPT Checkpoint Therapeutics
Oliviero James F III / director, officer: CEO, President and Director
12/18/2024
Sell
$3.87
602,167
$2.330M
3.41M
NASDAQ CGEM Cullinan Oncology
Michaelson Jennifer / officer: Chief Scientific Officer
12/12/2024
Sell
$12.52
3,489
$44K
104,453
NASDAQ CGEM Cullinan Oncology
SUMER JACQUELYN L / officer: Chief Legal Officer
12/18/2024
Sell
$11.41
3,482
$40K
90,651
NASDAQ CGEM Cullinan Oncology
Jones Jeffrey Alan / officer: Chief Medical Officer
12/18/2024
Sell
$11.41
4,632
$53K
114,059
NASDAQ CGEM Cullinan Oncology
Michaelson Jennifer / officer: Chief Scientific Officer
12/18/2024
Sell
$11.41
4,693
$54K
99,760
NASDAQ CYTK Cytokinetics
WIERENGA WENDALL / director
12/16/2024
Sell
$48.61
742
$36K
24,559
NASDAQ CTSO Cytosorbents
MARIANI PETER J / officer: Chief Financial Officer
12/13/2024
Buy
$0.96
20,000
$19K
401,363
NASDAQ DSGN Design Therapeutics
Prasad Deepa / director
12/18/2024
Sell
$6.27
3,806
$24K
20,000
NASDAQ DXCM DexCom
Sylvain Jereme M / officer: EVP, Chief Financal Officer
12/16/2024
Sell
$76.87
744
$57K
80,030
NASDAQ DXCM DexCom
Stern Sadie / officer: EVP, Chief HR Officer
12/16/2024
Sell
$76.87
424
$33K
70,768
NASDAQ DXCM DexCom
Heller Bridgette P / director
12/16/2024
Sell
$76.87
1,000
$77K
23,349
NASDAQ DXCM DexCom
Leach Jacob Steven / officer: EVP, Chief Operating Officer
12/16/2024
Sell
$76.87
744
$57K
264,171
NASDAQ DCGO DocGo
Leite Etalvina / director
12/17/2024
Sell
$4.34
16,500
$72K
51,411
NASDAQ DCGO DocGo
Tendler Ely D / director, officer: General Counsel and Secretary
12/16/2024
Sell
$4.44
23,088
$103K
175,645
NYSE EW Edwards Lifesciences
Lippis Daniel J. / officer: CVP, JAPAC
12/16/2024
Sell
$74.08
2,500
$185K
23,189
NASDAQ NVNO enVVeno Medical
Jenusaitis Matthew / director
12/19/2024
Buy
$2.53
9,620
$24K
16,545
NASDAQ NVNO enVVeno Medical
BERMAN ROBERT ANDREW / director, officer: Chief Executive Officer
12/19/2024
Buy
$2.55
12,000
$31K
222,236
NASDAQ ESPR Esperion
Koenig Sheldon L. / director, officer: President and CEO
12/17/2024
Sell
$2.47
12,447
$31K
739,819
NASDAQ ESPR Esperion
Warren Eric / officer: Chief Commercial Officer
12/17/2024
Sell
$2.43
2,234
$5K
160,121
NASDAQ ESPR Esperion
Halladay Benjamin / officer: Chief Financial Officer
12/17/2024
Sell
$2.42
3,245
$8K
240,691
NASDAQ WGS GeneDx
Stueland Katherine / director, officer: Chief Executive Officer
12/16/2024
Sell
$76.75
10,501
$806K
71,146
NASDAQ WGS GeneDx
Feeley Kevin / officer: CHIEF FINANCIAL OFFICER
12/16/2024
Sell
$76.75
3,728
$286K
28,200
NASDAQ GNLX Genelux
Zindrick Thomas / director, officer: President and CEO
12/16/2024
Sell
$2.34
14,315
$33K
37,372
NASDAQ GNLX Genelux
Cappello Joseph / officer: VP, Pharmaceutical Development
12/16/2024
Sell
$2.34
6,300
$15K
14,653
NASDAQ GNLX Genelux
Smalling Ralph / officer: Head of Regulatory
12/16/2024
Sell
$2.34
2,510
$6K
16,322
NASDAQ GNLX Genelux
Zak Lourie S. / officer: Chief Financial Officer
12/16/2024
Sell
$2.34
2,103
$5K
40,802
NASDAQ GILD Gilead Sciences
Dickinson Andrew D / officer: Chief Financial Officer
12/16/2024
Sell
$91.96
8,500
$782K
132,373
NYSE GKOS Glaukos
Gilliam Joseph E / officer: PRESIDENT & COO
12/20/2024
Sell
$150.35
1,292
$194K
102,169
NYSE GKOS Glaukos
Gilliam Joseph E / officer: PRESIDENT & COO
12/20/2024
Sell
$149.54
2,036
$304K
103,461
NYSE GKOS Glaukos
Kliman Gilbert H / director
12/20/2024
Sell
$150.28
10,000
$1.503M
32,336
NYSE GKOS Glaukos
Kliman Gilbert H / director
12/11/2024
Sell
$144.01
2,000
$288K
32,336
NASDAQ GH Guardant Health
Tariq Musa / director
12/18/2024
Sell
$34.85
116
$4K
2,810
NASDAQ GH Guardant Health
Tariq Musa / director
12/13/2024
Sell
$35.00
2,320
$81K
2,676
NASDAQ GYRE Gyre Therapeutics
Ma Songjiang / director, officer: President
12/20/2024
Sell
$10.90
2,000
$22K
2.93M
NASDAQ GYRE Gyre Therapeutics
Ma Songjiang / director, officer: President
12/19/2024
Sell
$10.82
2,000
$22K
2.94M
NASDAQ HCAT Health Catalyst
Llewelyn Linda / officer: Chief People Officer
12/16/2024
Sell
$7.88
6,442
$51K
98,702
NASDAQ IGMS IGM Biosciences
Tahir Misbah / officer: CHIEF FINANCIAL OFFICER
12/16/2024
Sell
$7.48
1,708
$13K
187,653
NASDAQ IGMS IGM Biosciences
Harler Mary Beth / director, officer: Chief Executive Officer
12/16/2024
Sell
$7.48
1,708
$13K
347,032
NASDAQ IGMS IGM Biosciences
Decker Lisa Lynn / officer: CHIEF BUSINESS OFFICER
12/16/2024
Sell
$7.48
1,063
$8K
78,041
NASDAQ IGMS IGM Biosciences
Weber Steven / officer: PRINCIPAL ACCOUNTING OFFICER
12/16/2024
Sell
$7.48
539
$4K
31,704
NASDAQ NARI Inari Medical
Hykes Andrew / director, officer: President and CEO
12/20/2024
Sell
$55.65
600
$33K
439,310
NASDAQ NARI Inari Medical
Hoffman William / director
12/16/2024
Sell
$55.27
10,301
$569K
448,832
NASDAQ NARI Inari Medical
Hykes Andrew / director, officer: President and CEO
12/20/2024
Sell
$55.20
2,400
$132K
439,910
NASDAQ NARI Inari Medical
Hoffman William / director
12/16/2024
Sell
$54.42
2,100
$114K
459,133
NASDAQ NARI Inari Medical
Hoffman William / director
12/16/2024
Sell
$56.82
2,347
$133K
461,233
NASDAQ NARI Inari Medical
Hoffman William / director
12/16/2024
Sell
$56.45
13,560
$765K
463,580
NASDAQ NARI Inari Medical
Hoffman William / director
12/16/2024
Sell
$56.89
132
$8K
441,233
NASDAQ NARI Inari Medical
Hoffman William / director
12/16/2024
Sell
$55.23
20,917
$1.155M
477,140
NASDAQ NARI Inari Medical
Hoffman William / director
12/16/2024
Sell
$56.51
7,467
$422K
441,365
NASDAQ NARI Inari Medical
Hoffman William / director
12/16/2024
Sell
$54.33
3,176
$173K
498,057
NASDAQ INCY Incyte
Tray Thomas / officer: Principal Accounting Officer
12/16/2024
Sell
$69.31
650
$45K
23,312
NASDAQ INCY Incyte
Tray Thomas / officer: Principal Accounting Officer
12/13/2024
Sell
$70.64
650
$46K
23,962
NASDAQ NOTV Inotiv
Landman David / director
12/19/2024
Buy
$4.25
23,529
$100K
176,851
NASDAQ INSM Insmed
Lewis William / director, officer: Chair and CEO
12/19/2024
Sell
$70.61
1,590
$112K
233,924
NASDAQ INSM Insmed
Lewis William / director, officer: Chair and CEO
12/19/2024
Sell
$69.71
5,240
$365K
235,514
NASDAQ INSM Insmed
Lewis William / director, officer: Chair and CEO
12/19/2024
Sell
$70.52
5,588
$394K
384,960
NASDAQ INSM Insmed
Lewis William / director, officer: Chair and CEO
12/19/2024
Sell
$69.65
13,162
$917K
390,548
NASDAQ IVVD Invivyd
MCGUIRE TERRANCE / director
12/17/2024
Sell
$0.48
97,410
$47K
3.91M
NASDAQ IVVD Invivyd
MCGUIRE TERRANCE / director
12/16/2024
Sell
$0.47
65,359
$31K
4.01M
NASDAQ IVVD Invivyd
MCGUIRE TERRANCE / director
12/12/2024
Sell
$0.58
125,000
$73K
4.08M
NASDAQ IVVD Invivyd
MCGUIRE TERRANCE / director
12/19/2024
Sell
$0.43
152,067
$66K
3.69M
NASDAQ IVVD Invivyd
MCGUIRE TERRANCE / director
12/18/2024
Sell
$0.47
74,764
$35K
3.84M
NASDAQ IOBT IO Biotech
Zocca Mai-Britt / director, officer: Chief Executive Officer
12/23/2024
Buy
$0.81
12,500
$10K
49,891
NASDAQ IOBT IO Biotech
Smith Devin Whittemore / officer: General Counsel
12/23/2024
Buy
$0.81
12,000
$10K
16,938
NASDAQ IOBT IO Biotech
Sullivan Amy / officer: Chief Financial Officer
12/23/2024
Buy
$0.83
10,250
$8K
84,632
NASDAQ LFWD Lifeward
Turk Joseph E Jr / director
12/13/2024
Buy
$1.69
6,000
$10K
18,516
NASDAQ MRKR Marker Therapeutics
New Enterprise Associates 16, L.P. / 10 percent owner
12/23/2024
Buy
$3.20
554,250
$1.774M
1.63M
TSX.V MRVL Marvel Biosciences
Meintjes Willem A / officer: Chief Financial Officer
12/16/2024
Sell
$122.50
1,500
$184K
112,711
TSX.V MRVL Marvel Biosciences
Koopmans Chris / officer: EVP, Chief Operations Officer
12/16/2024
Sell
$122.50
6,000
$735K
97,244
TSX.V MIR MedMira
Eloy Loic / officer: Technologies Group President
12/13/2024
Sell
$17.89
44,000
$787K
133,663
NASDAQ NTRA Natera
Rabinowitz Matthew / director, officer: EXECUTIVE CHAIRMAN
12/13/2024
Sell
$168.36
5,300
$892K
2.39M
NASDAQ NTRA Natera
Sheena Jonathan / director, other: CO-FOUNDER
12/18/2024
Sell
$167.25
1,825
$305K
257,609
NASDAQ NTRA Natera
Sheena Jonathan / director, other: CO-FOUNDER
12/18/2024
Sell
$165.98
338
$56K
259,434
NASDAQ NTRA Natera
Sheena Jonathan / director, other: CO-FOUNDER
12/18/2024
Sell
$167.18
959
$160K
46,585
NASDAQ NTRA Natera
Rabinowitz Matthew / director, officer: EXECUTIVE CHAIRMAN
12/13/2024
Sell
$167.39
4,927
$825K
2.39M
NASDAQ NTRA Natera
Sheena Jonathan / director, other: CO-FOUNDER
12/18/2024
Sell
$167.07
852
$142K
46,778
NASDAQ NTRA Natera
Rabinowitz Matthew / director, officer: EXECUTIVE CHAIRMAN
12/13/2024
Sell
$166.45
45,769
$7.618M
2.40M
NASDAQ NTRA Natera
Sheena Jonathan / director, other: CO-FOUNDER
12/18/2024
Sell
$166.18
238
$40K
47,544
NASDAQ NTRA Natera
Rabinowitz Matthew / director, officer: EXECUTIVE CHAIRMAN
12/13/2024
Sell
$165.45
75,323
$12.462M
2.45M
NASDAQ NTRA Natera
Sheena Jonathan / director, other: CO-FOUNDER
12/18/2024
Sell
$166.01
152
$25K
47,630
NASDAQ NTRA Natera
Sheena Jonathan / director, other: CO-FOUNDER
12/18/2024
Sell
$168.02
496
$83K
46,282
NASDAQ NTRA Natera
Rabinowitz Matthew / director, officer: EXECUTIVE CHAIRMAN
12/13/2024
Sell
$164.61
28,681
$4.721M
2.52M
NASDAQ NTRA Natera
Sheena Jonathan / director, other: CO-FOUNDER
12/18/2024
Sell
$168.15
537
$90K
257,072
NASDAQ NTRA Natera
Sheena Jonathan / director, other: CO-FOUNDER
12/18/2024
Sell
$168.04
303
$51K
46,282
NASDAQ NKTR Nektar Therapeutics
Zalevsky Jonathan / officer: Chief R&D Officer
12/19/2024
Sell
$0.94
51,115
$48K
326,904
NASDAQ NKTR Nektar Therapeutics
ROBIN HOWARD W / director, officer: President & CEO
12/18/2024
Sell
$0.99
85,035
$84K
1.11M
NASDAQ NKTR Nektar Therapeutics
ROBIN HOWARD W / director, officer: President & CEO
12/17/2024
Sell
$1.01
46,995
$47K
1.20M
NYSE NEUE NeueHealth
Mikan George Lawrence III / director, officer: CEO & President
12/17/2024
Sell
$4.18
16,803
$70K
83,029
NASDAQ NBIX Neurocrine Biosciences
Delaet Ingrid / officer: Chief Regulatory Officer
12/17/2024
Sell
$135.00
1,091
$147K
2,507
NASDAQ NAMS NewAmsterdam Pharma
ForGrowth NAP B.V. / 10 percent owner
12/12/2024
Sell
$25.25
140,048
$3.536M
11.18M
NASDAQ NAMS NewAmsterdam Pharma
ForGrowth NAP B.V. / 10 percent owner
12/18/2024
Sell
$26.55
46,210
$1.227M
10.91M
NASDAQ NAMS NewAmsterdam Pharma
ForGrowth NAP B.V. / 10 percent owner
12/16/2024
Sell
$25.00
1,096
$27K
11.12M
NASDAQ NAMS NewAmsterdam Pharma
ForGrowth NAP B.V. / 10 percent owner
12/18/2024
Sell
$25.72
54,518
$1.402M
10.95M
NASDAQ NAMS NewAmsterdam Pharma
Bain Capital Life Sciences Investors, LLC / 10 percent owner
12/13/2024
Buy
$0.0001
1.63M
$163
1.63M
NASDAQ NAMS NewAmsterdam Pharma
ForGrowth NAP B.V. / 10 percent owner
12/13/2024
Sell
$25.01
25,751
$644K
11.12M
NASDAQ NAMS NewAmsterdam Pharma
ForGrowth NAP B.V. / 10 percent owner
12/17/2024
Sell
$26.45
47,736
$1.262M
11.01M
NASDAQ NAMS NewAmsterdam Pharma
ForGrowth NAP B.V. / 10 percent owner
12/12/2024
Sell
$26.18
25,963
$680K
11.15M
NASDAQ NAMS NewAmsterdam Pharma
ForGrowth NAP B.V. / 10 percent owner
12/19/2024
Sell
$25.45
56,506
$1.438M
10.85M
NASDAQ NAMS NewAmsterdam Pharma
ForGrowth NAP B.V. / 10 percent owner
12/17/2024
Sell
$25.60
66,648
$1.706M
11.06M
NASDAQ NXGL NEXGEL
Henry Scott Robert / director
12/20/2024
Sell
$4.64
3,000
$14K
144,553
NASDAQ NRXP NRx Pharmaceuticals
Javitt Jonathan C / director, 10 percent owner, officer: Chairman and Chief Scientist
12/17/2024
Buy
$1.17
40,000
$47K
84,634
NASDAQ NUVL Nuvalent
Porter James Richard / director, officer: President and CEO
12/16/2024
Sell
$86.96
8,031
$698K
188,113
NASDAQ NUVL Nuvalent
Porter James Richard / director, officer: President and CEO
12/16/2024
Sell
$86.46
18,969
$1.640M
196,144
NASDAQ NVCT Nuvectis Pharma
Mosseri Marlio Charles / 10 percent owner
12/13/2024
Buy
$4.70
17,000
$80K
2.61M
NASDAQ OLMA Olema Oncology
Graham G. Walmsley / director
12/17/2024
Sell
$6.75
700,761
$4.730M
1.41M
NASDAQ OLMA Olema Oncology
Graham G. Walmsley / director
12/13/2024
Buy
$6.75
700,761
$4.730M
700,761
NASDAQ OLMA Olema Oncology
Graham G. Walmsley / director
12/13/2024
Sell
$6.75
700,761
$4.730M
0
NASDAQ OLMA Olema Oncology
Graham G. Walmsley / director
12/17/2024
Sell
$6.75
700,761
$4.730M
0
NASDAQ OPRX OptimizeRx
FEBBO WILLIAM J / director, officer: CEO
12/12/2024
Buy
$5.01
20,000
$100K
601,253
NASDAQ OPTN OptiNose
Marino Michael F III / officer: Chief Legal Officer & Corp Sec
12/17/2024
Sell
$0.44
3,050
$1K
544,188
NASDAQ OPTN OptiNose
Mahmoud Ramy A / director, officer: Chief Executive Officer
12/17/2024
Sell
$0.44
4,614
$2K
1.20M
NASDAQ OBIO Orchestra BioMed
Taylor Andrew Lawrence / officer: Chief Financial Officer
12/19/2024
Buy
$4.83
1,000
$5K
344,960
NASDAQ OBIO Orchestra BioMed
Hochman David P / director, officer: See Remarks
12/18/2024
Buy
$4.91
5,000
$25K
575,498
NASDAQ ORGO Organogenesis
Gillheeney Gary S. / director, officer: President and CEO
12/16/2024
Sell
$3.49
5,585
$19K
3.04M
NASDAQ ORGO Organogenesis
Gillheeney Gary S. / director, officer: President and CEO
12/13/2024
Sell
$3.36
55,615
$187K
3.04M
NASDAQ ORIC ORIC Pharmaceuticals
Multani Pratik S / officer: Chief Medical Officer
12/16/2024
Sell
$8.28
8,850
$73K
46,765
NASDAQ ORIC ORIC Pharmaceuticals
Piscitelli Dominic / officer: Chief Financial Officer
12/16/2024
Sell
$8.28
8,851
$73K
106,764
NASDAQ ORIC ORIC Pharmaceuticals
Chacko Jacob / director, officer: PRESIDENT AND CEO
12/16/2024
Sell
$8.28
24,660
$204K
778,648
NASDAQ OFIX Orthofix Medical
Gillespie Geoffrey C / officer: CAO
12/17/2024
Sell
$17.84
26
$464
41,041
NYSE OWLT Owlet
Workman Kurt / director, officer: Chief Executive Officer
12/16/2024
Sell
$4.86
893
$4K
338,769
NASDAQ PCRX Pacira BioSciences
GAUGLER DARYL / officer: Chief Operating Officer
12/13/2024
Sell
$19.76
500
$10K
115,199
NYSE PEN Penumbra
Elsesser Adam / director, officer: CEO and President
12/20/2024
Sell
$240.79
800
$193K
851,782
NYSE PEN Penumbra
Elsesser Adam / director, officer: CEO and President
12/20/2024
Sell
$244.75
1,029
$252K
837,582
NYSE PEN Penumbra
Elsesser Adam / director, officer: CEO and President
12/20/2024
Sell
$243.91
3,698
$902K
838,611
NYSE PEN Penumbra
Elsesser Adam / director, officer: CEO and President
12/20/2024
Sell
$242.94
5,435
$1.320M
842,309
NYSE PEN Penumbra
Elsesser Adam / director, officer: CEO and President
12/20/2024
Sell
$242.10
4,038
$978K
847,744
NASDAQ PSNL Personalis
Chen Richard / officer: CHIEF MEDICAL OFFICER AND EVP
12/16/2024
Sell
$3.82
4,834
$18K
123,886
NASDAQ PSNL Personalis
Tachibana Aaron / officer: CFO AND COO
12/16/2024
Sell
$3.82
6,865
$26K
167,098
NASDAQ PSNL Personalis
Moore Stephen Michael / officer: SVP and Chief Legal Officer
12/16/2024
Sell
$3.82
1,513
$6K
65,875
NASDAQ PHAT Phathom Pharmaceuticals
Parikh Asit / director
12/13/2024
Buy
$8.12
10,000
$81K
75,500
NASDAQ PHAT Phathom Pharmaceuticals
KARBE FRANK / director
12/13/2024
Buy
$7.93
12,500
$99K
57,000
NASDAQ PHAT Phathom Pharmaceuticals
Henderson Molly / officer: CFO and CBO
12/19/2024
Sell
$8.00
1,291
$10K
98,156
NASDAQ PHAT Phathom Pharmaceuticals
Nabulsi Azmi / officer: Chief Operating Officer
12/19/2024
Sell
$8.00
1,118
$9K
239,303
NYSE PHR Phreesia
Linetsky David / officer: SVP, Life Sciences
12/17/2024
Sell
$25.77
2
$52
8,875
NYSE PHR Phreesia
Linetsky David / officer: SVP, Life Sciences
12/18/2024
Sell
$25.38
24
$609
8,851
NYSE PHR Phreesia
Linetsky David / officer: SVP, Life Sciences
12/17/2024
Sell
$25.04
59
$1K
8,877
NYSE PHR Phreesia
Weintraub Michael / director
12/13/2024
Sell
$25.04
20,565
$515K
242,827
NYSE PHR Phreesia
Hoffman Allison C / officer: General Counsel & Secretary
12/18/2024
Sell
$24.88
3,495
$87K
116,296
NYSE PHR Phreesia
Linetsky David / officer: SVP, Life Sciences
12/16/2024
Sell
$24.88
35
$871
8,936
NYSE PHR Phreesia
Weintraub Michael / director
12/16/2024
Sell
$25.26
861
$22K
242,827
NASDAQ PRPO Precipio
SANDBERG RICHARD A / director
11/11/2024
Sell
$6.03
2,000
$12K
16,525
NASDAQ PRPO Precipio
SANDBERG RICHARD A / director
12/13/2024
Sell
$5.88
12,000
$71K
4,525
NASDAQ PRPO Precipio
SANDBERG RICHARD A / director
12/13/2024
Buy
$6.10
15,000
$91K
19,525
NASDAQ PRLD Prelude Therapeutics
Vaddi Krishna / director, officer: CEO
12/19/2024
Buy
$0.89
6,888
$6K
127,553
NASDAQ PRLD Prelude Therapeutics
Vaddi Krishna / director, officer: CEO
12/18/2024
Buy
$0.93
100,000
$93K
1.17M
NASDAQ PRLD Prelude Therapeutics
Lim Bryant David / officer: CLO, Interim CFO, Corp Sec.
12/19/2024
Buy
$0.91
25,000
$23K
27,400
NASDAQ PINC Premier
Anderson Leigh / officer: Chief Operating Officer
12/20/2024
Sell
$21.88
20,000
$438K
111,707
NASDAQ PMD Psychemedics
Powell Anderson Capital Partners LLC / 10 percent owner
12/17/2024
Buy
$1.87
9,850
$18K
614,406
NASDAQ PMD Psychemedics
Powell Anderson Capital Partners LLC / 10 percent owner
12/16/2024
Buy
$1.97
30,000
$59K
360,000
NASDAQ PMD Psychemedics
Powell Anderson Capital Partners LLC / 10 percent owner
12/17/2024
Buy
$1.87
9,850
$18K
369,850
NASDAQ PMD Psychemedics
Powell Anderson Capital Partners LLC / 10 percent owner
12/13/2024
Buy
$1.88
80,000
$150K
574,556
NASDAQ PMD Psychemedics
Powell Anderson Capital Partners LLC / 10 percent owner
12/16/2024
Buy
$1.97
30,000
$59K
604,556
NASDAQ PLSE Pulse Biosciences
DUGGAN ROBERT W / director, 10 percent owner:
12/13/2024
Buy
$17.18
55,256
$949K
42.33M
NASDAQ PLSE Pulse Biosciences
Barrett Burke Thomas / other: Former President and CEO
12/11/2024
Sell
$17.42
50,000
$871K
63,172
NASDAQ PLSE Pulse Biosciences
DUGGAN ROBERT W / director, 10 percent owner:
12/11/2024
Buy
$16.74
6,054
$101K
42.18M
NASDAQ PLSE Pulse Biosciences
DUGGAN ROBERT W / director, 10 percent owner:
12/11/2024
Buy
$17.42
50,000
$871K
42.23M
NASDAQ RANI Rani Therapeutics
McKinley Kate / officer: Chief Business Officer
12/13/2024
Buy
$1.67
17,960
$30K
17,960
NASDAQ RLAY Relay Therapeutics
Patel Sanjiv / director, officer: President and CEO
12/16/2024
Sell
$5.00
100,000
$500K
574,548
NASDAQ REPL Replimune
Patel Sushil / director, officer: Chief Executive Officer
12/16/2024
Sell
$12.42
10,000
$124K
202,014
NYSEAMEX RVP Retractable Technologies
SHAW THOMAS J / director, 10 percent owner, officer: PRESIDENT AND CEO
12/19/2024
Buy
$0.62
2,518
$2K
14.92M
NYSEAMEX RVP Retractable Technologies
SHAW THOMAS J / director, 10 percent owner, officer: PRESIDENT AND CEO
12/17/2024
Buy
$0.63
1,112
$704
14.89M
NYSEAMEX RVP Retractable Technologies
SHAW THOMAS J / director, 10 percent owner, officer: PRESIDENT AND CEO
12/18/2024
Buy
$0.60
28,596
$17K
14.92M
NASDAQ RZLT Rezolute
Evans Daron / officer: CFO
12/18/2024
Buy
$4.29
10,000
$43K
150,900
NASDAQ ROIV Roivant
Sukhatme Mayukh / director, officer: Pres&Chief Investment Officer
12/18/2024
Sell
$12.05
412,584
$4.972M
18.84M
NASDAQ SRPT Sarepta Therapeutics
Wigzell Hans Lennart Rudolf / director
12/12/2024
Sell
$124.84
10,500
$1.311M
22,840
NASDAQ SVRA Savara
Pauls Matthew / director, officer: CHIEF EXECUTIVE OFFICER
12/16/2024
Sell
$3.31
54,702
$181K
1.54M
NASDAQ SVRA Savara
Lowrance David L / officer: Chief Financial Officer
12/16/2024
Sell
$3.33
25,000
$83K
381,005
NASDAQ SVRA Savara
Hawkins Richard J / director
12/16/2024
Sell
$3.32
8,000
$27K
67,241
NASDAQ SCLX Scilex
SHAH JAISIM / director, officer: See Remarks
12/18/2024
Buy
$0.46
30,000
$14K
139,333
NYSEAMEX SENS Senseonics
ROEDER DOUGLAS A / director
12/12/2024
Buy
$0.41
300,000
$123K
1.39M
NYSEAMEX SENS Senseonics
ROEDER DOUGLAS A / director
12/13/2024
Buy
$0.50
75,000
$38K
1.46M
NYSEAMEX SENS Senseonics
ROEDER DOUGLAS A / director
12/13/2024
Buy
$0.50
25,000
$13K
1.41M
NASDAQ SILO Silo Pharma
Weisblum Eric / director, officer: CEO and President
12/13/2024
Buy
$0.84
2,500
$2K
187,932
NASDAQ OMIC Singular Genomics
Spaventa Andrew / director, officer: Chief Executive Officer
12/16/2024
Sell
$20.16
180
$4K
631
NASDAQ STAA STAAR Surgical
BROADWOOD PARTNERS, L.P. / 10 percent owner
12/16/2024
Buy
$24.15
46,220
$1.116M
10.81M
NASDAQ STAA STAAR Surgical
BROADWOOD PARTNERS, L.P. / 10 percent owner
12/16/2024
Buy
$24.83
7,280
$181K
10.82M
NASDAQ STAA STAAR Surgical
BROADWOOD PARTNERS, L.P. / 10 percent owner
12/17/2024
Buy
$24.58
3,700
$91K
10.83M
NASDAQ STAA STAAR Surgical
BROADWOOD PARTNERS, L.P. / 10 percent owner
12/18/2024
Buy
$24.33
23,000
$559K
10.85M
NASDAQ THAR Tharimmune
MILBY RANDY / director, officer: CEO
12/19/2024
Buy
$2.12
4,600
$10K
17,534
NASDAQ TLSI TriSalus Life Sciences
Frankenius Equity AB / 10 percent owner
12/17/2024
Buy
$3.97
62,972
$250K
6.23M
NASDAQ TCRX TScan Therapeutics
Lynx1 Capital Management LP / 10 percent owner
12/12/2024
Buy
$3.01
31,800
$96K
5.26M
NASDAQ TCRX TScan Therapeutics
Lynx1 Capital Management LP / 10 percent owner
12/13/2024
Buy
$2.90
100,000
$290K
5.36M
NASDAQ UTHR United Therapeutics
SULLIVAN LOUIS W / director
12/18/2024
Sell
$366.11
1,121
$410K
30,139
NASDAQ UTHR United Therapeutics
SULLIVAN LOUIS W / director
12/18/2024
Sell
$371.25
200
$74K
23,031
NASDAQ UTHR United Therapeutics
SULLIVAN LOUIS W / director
12/18/2024
Sell
$373.06
1,525
$569K
11,957
NASDAQ UTHR United Therapeutics
SULLIVAN LOUIS W / director
12/18/2024
Sell
$380.12
700
$266K
16,980
NASDAQ UTHR United Therapeutics
BENKOWITZ MICHAEL / officer: PRESIDENT AND COO
12/16/2024
Sell
$368.94
1,336
$493K
5,196
NASDAQ UTHR United Therapeutics
SULLIVAN LOUIS W / director
12/18/2024
Sell
$381.37
800
$305K
5,151
NASDAQ UTHR United Therapeutics
BENKOWITZ MICHAEL / officer: PRESIDENT AND COO
12/16/2024
Sell
$369.57
800
$296K
1,300
NASDAQ UTHR United Therapeutics
SULLIVAN LOUIS W / director
12/18/2024
Sell
$373.12
1,501
$560K
23,231
NASDAQ UTHR United Therapeutics
SULLIVAN LOUIS W / director
12/18/2024
Sell
$370.78
100
$37K
13,482
NASDAQ UTHR United Therapeutics
SULLIVAN LOUIS W / director
12/18/2024
Sell
$379.30
200
$76K
17,680
NASDAQ UTHR United Therapeutics
BENKOWITZ MICHAEL / officer: PRESIDENT AND COO
12/16/2024
Sell
$367.70
768
$282K
6,532
NASDAQ UTHR United Therapeutics
SULLIVAN LOUIS W / director
12/18/2024
Sell
$370.02
1,926
$713K
13,582
NASDAQ UTHR United Therapeutics
BENKOWITZ MICHAEL / officer: PRESIDENT AND COO
12/16/2024
Sell
$370.96
1,981
$735K
1,705
NASDAQ UTHR United Therapeutics
BENKOWITZ MICHAEL / officer: PRESIDENT AND COO
12/16/2024
Sell
$364.97
100
$36K
7,300
NASDAQ UTHR United Therapeutics
SULLIVAN LOUIS W / director
12/18/2024
Sell
$379.67
944
$358K
5,951
NASDAQ UTHR United Therapeutics
BENKOWITZ MICHAEL / officer: PRESIDENT AND COO
12/16/2024
Sell
$372.15
500
$186K
0
NASDAQ UTHR United Therapeutics
SULLIVAN LOUIS W / director
12/18/2024
Sell
$370.30
1,400
$518K
24,732
NASDAQ UTHR United Therapeutics
SULLIVAN LOUIS W / director
12/18/2024
Sell
$374.46
500
$187K
17,880
NASDAQ UTHR United Therapeutics
BENKOWITZ MICHAEL / officer: PRESIDENT AND COO
12/16/2024
Sell
$368.16
300
$110K
2,100
NASDAQ UTHR United Therapeutics
BENKOWITZ MICHAEL / officer: PRESIDENT AND COO
12/16/2024
Sell
$363.25
100
$36K
7,400
NASDAQ UTHR United Therapeutics
SULLIVAN LOUIS W / director
12/18/2024
Sell
$377.46
400
$151K
6,895
NASDAQ UTHR United Therapeutics
SULLIVAN LOUIS W / director
12/18/2024
Sell
$368.67
752
$277K
15,508
NASDAQ UTHR United Therapeutics
BENKOWITZ MICHAEL / officer: PRESIDENT AND COO
12/16/2024
Sell
$372.60
61
$23K
0
NASDAQ UTHR United Therapeutics
SULLIVAN LOUIS W / director
12/18/2024
Sell
$369.32
2,100
$776K
26,132
NASDAQ UTHR United Therapeutics
SULLIVAN LOUIS W / director
12/18/2024
Sell
$375.00
2,200
$825K
18,380
NASDAQ UTHR United Therapeutics
BENKOWITZ MICHAEL / officer: PRESIDENT AND COO
12/16/2024
Sell
$363.25
100
$36K
2,400
NASDAQ UTHR United Therapeutics
SULLIVAN LOUIS W / director
12/18/2024
Sell
$375.03
2,700
$1.013M
7,295
NASDAQ UTHR United Therapeutics
SULLIVAN LOUIS W / director
12/18/2024
Sell
$382.63
100
$38K
16,260
NASDAQ UTHR United Therapeutics
SULLIVAN LOUIS W / director
12/18/2024
Sell
$368.50
1,307
$482K
28,232
NASDAQ UTHR United Therapeutics
BENKOWITZ MICHAEL / officer: PRESIDENT AND COO
12/16/2024
Sell
$372.18
1,644
$612K
61
NASDAQ UTHR United Therapeutics
SULLIVAN LOUIS W / director
12/18/2024
Sell
$366.97
600
$220K
29,539
NASDAQ UTHR United Therapeutics
SULLIVAN LOUIS W / director
12/18/2024
Sell
$374.14
2,451
$917K
20,580
NASDAQ UTHR United Therapeutics
BENKOWITZ MICHAEL / officer: PRESIDENT AND COO
12/16/2024
Sell
$369.90
1,510
$559K
3,686
NASDAQ UTHR United Therapeutics
SULLIVAN LOUIS W / director
12/18/2024
Sell
$374.17
1,962
$734K
9,995
NASDAQ UTHR United Therapeutics
SULLIVAN LOUIS W / director
12/18/2024
Sell
$381.41
620
$236K
16,360
NASDAQ UTHR United Therapeutics
SULLIVAN LOUIS W / director
12/18/2024
Sell
$382.25
100
$38K
5,051
NASDAQ UTHR United Therapeutics
BENKOWITZ MICHAEL / officer: PRESIDENT AND COO
12/16/2024
Sell
$370.93
800
$297K
500
NASDAQ PCVX Vaxcyte
GUGGENHIME ANDREW / officer: PRESIDENT AND CFO
12/18/2024
Sell
$89.31
3,157
$282K
109,771
NASDAQ PCVX Vaxcyte
GUGGENHIME ANDREW / officer: PRESIDENT AND CFO
12/18/2024
Sell
$88.70
3,373
$299K
112,928
NASDAQ PCVX Vaxcyte
GUGGENHIME ANDREW / officer: PRESIDENT AND CFO
12/18/2024
Sell
$87.26
1,190
$104K
116,301
NASDAQ PCVX Vaxcyte
GUGGENHIME ANDREW / officer: PRESIDENT AND CFO
12/18/2024
Sell
$90.24
280
$25K
109,491
NASDAQ VTYX Ventyx Biosciences
Nuss John / officer: CHIEF SCIENTIFIC OFFICER
12/19/2024
Sell
$2.26
13,161
$30K
485,701
NASDAQ VCYT Veracyte
Stapley Marc / director, officer: Chief Executive Officer
12/13/2024
Sell
$44.14
400
$18K
307,345
NASDAQ VCYT Veracyte
Stapley Marc / director, officer: Chief Executive Officer
12/13/2024
Sell
$43.37
5,190
$225K
307,745
NASDAQ VSTM Verastem Oncology
Stuglik Brian M / director
12/16/2024
Sell
$4.54
595
$3K
95,514
NASDAQ VSTM Verastem Oncology
Gagnon Robert E. / director
12/19/2024
Sell
$4.37
130
$568
34,477
NASDAQ VSTM Verastem Oncology
Paterson Dan / director, officer: President and CEO
12/19/2024
Sell
$4.37
183
$800
231,149
NASDAQ VSTM Verastem Oncology
Gagnon Robert E. / director
12/16/2024
Sell
$4.54
285
$1K
34,607
NASDAQ VSTM Verastem Oncology
Paterson Dan / director, officer: President and CEO
12/16/2024
Sell
$4.54
244
$1K
231,332
NASDAQ VSTM Verastem Oncology
Stuglik Brian M / director
12/19/2024
Sell
$4.37
334
$1K
95,180
NASDAQ VIGL Vigil Neuroscience
Magovcevic-Liebisch Ivana / director, officer: President and CEO
12/19/2024
Buy
$1.68
5,000
$8K
222,687
NASDAQ VIGL Vigil Neuroscience
Budd Haeberlein Samantha L. / director
12/19/2024
Buy
$1.71
12,000
$21K
12,000
NASDAQ VIGL Vigil Neuroscience
Magovcevic-Liebisch Ivana / director, officer: President and CEO
12/18/2024
Buy
$1.67
5,000
$8K
217,687
NYSE WRBY Warby Parker
Gilboa David Abraham / director, officer: Co-Chief Executive Officer
12/18/2024
Sell
$25.09
55,788
$1.400M
12,306
NYSE WRBY Warby Parker
Blumenthal Neil Harris / director, officer: Co-Chief Executive Officer
12/18/2024
Sell
$25.09
56,054
$1.406M
12,177
NASDAQ WAY Waystar
Oreskovich Steven M / officer: Chief Financial Officer
12/12/2024
Sell
$34.21
47
$2K
173,642
NASDAQ WAY Waystar
Oreskovich Steven M / officer: Chief Financial Officer
12/12/2024
Sell
$33.89
16,619
$563K
173,689
NASDAQ XENE Xenon Pharmaceuticals
AULIN SHERRY / officer: Chief Financial Officer
12/18/2024
Sell
$41.23
7,199
$297K
0
NASDAQ XENE Xenon Pharmaceuticals
AULIN SHERRY / officer: Chief Financial Officer
12/18/2024
Sell
$41.19
11,510
$474K
0
NASDAQ XLO Xilio Therapeutics
GILEAD SCIENCES, INC. / 10 percent owner
12/18/2024
Buy
$1.04
1.76M
$1.830M
9.11M
NASDAQ XLO Xilio Therapeutics
GILEAD SCIENCES, INC. / 10 percent owner
12/18/2024
Buy
$0.0001
6.09M
$609
9.98M

COPYRIGHT ©2023 HEALTH STOCKS HUB

  Research Tools
  News & Announcements
  Popular Topics
  Miscellaneous